Chronic, Refractory

Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveInsight

Published on 08/07/2025 at 18:09 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

 
+14699457679

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/chronic-refractory-cough-market-still-unexplored-with-pharma-companies-eyeing-first-mover-advantage-in-the-us--delveinsight-302309442.html

en | boerse | 67920850 |